Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
- PMID: 32532826
- PMCID: PMC7316117
- DOI: 10.1136/medethics-2020-106516
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
Abstract
The urgent drive for vaccine development in the midst of the current COVID-19 pandemic has prompted public and private organisations to invest heavily in research and development of a COVID-19 vaccine. Organisations globally have affirmed the commitment of fair global access, but the means by which a successful vaccine can be mass produced and equitably distributed remains notably unanswered. Barriers for low-income countries include the inability to afford vaccines as well as inadequate resources to vaccinate, barriers that are exacerbated during a pandemic. Fair distribution of a pandemic vaccine is unlikely without a solid ethical framework for allocation. This piece analyses four allocation paradigms: ability to develop or purchase; reciprocity; ability to implement; and distributive justice, and synthesises their ethical considerations to develop an allocation model to fit the COVID-19 pandemic.
Keywords: clinical ethics; distributive justice.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- Khamsi R. If a coronavirus vaccine arrives, can the world make enough? nature, 2020. Available: https://www.nature.com/articles/d41586-020-01063-8 [Accessed 9 Apr 2020]. - PubMed
-
- Commitment and call to action: global collaboration to accelerate new COVID-19 health technologies, 2020. Available: https://www.who.int/news-room/detail/24-04-2020-commitment-and-call-to-a... [Accessed 27 Apr 2020].
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical